van den Berg R J, Kuijper E J, van Coppenraet L E S Bruijnesteijn, Claas E C J
Department of Medical Microbiology, Center of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
Clin Microbiol Infect. 2006 Feb;12(2):184-6. doi: 10.1111/j.1469-0691.2005.01301.x.
A real-time PCR assay for Clostridium difficile was developed, based on the tcdB gene, which detected all known toxinogenic reference strains (n = 45), within 30 serogroups and 24 toxinotypes. The analytical sensitivity was 1 x 10(3) CFU/mL, and the detection limit in faeces was 1 x 10(5) CFU/g. The optimal protocol for DNA extraction from faecal samples involved use of the MagnaPure system with a Stool Transport and Recovery (STAR) buffer pre-treatment. In a 1-month prospective study of 85 patients with diarrhoea, the sensitivity, specificity and positive and negative predictive values of the assay were 100%, 94%, 55% and 100%, respectively, compared with the standard cell cytotoxicity assay.
基于tcdB基因开发了一种艰难梭菌实时PCR检测方法,该方法可检测30个血清群和24个毒素型内的所有已知产毒素参考菌株(n = 45)。分析灵敏度为1×10³ CFU/mL,粪便中的检测限为1×10⁵ CFU/g。从粪便样本中提取DNA的最佳方案包括使用带有粪便转运和回收(STAR)缓冲液预处理的MagnaPure系统。在一项对85例腹泻患者进行的为期1个月的前瞻性研究中,与标准细胞毒性试验相比,该检测方法的灵敏度、特异性以及阳性和阴性预测值分别为100%、94%、55%和100%。